See how we've tackled industry pain points in past clinical trials. Find our latest case studies below.
A multi-national European pharmaceutical and consumer health company required clinical data to validate the safety and performance of five of its nasal spray and allergy products post CE-mark, in accordance with MDR 2017/745 Annex XIV Part B.
This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.
It is notoriously difficult to conduct studies with cohorts of young children and their caregivers due to participant burden and subjectivity in patient-reported outcomes. This fully virtual study, the first of its kind targeting infants and caregivers, will leverage digital instruments and AI to capture and quantify infant cries as a key outcome for colic symptoms and quality-of-life endpoints.
A multinational food company needed to assess the safety and efficacy of rice vinegar as a treatment for pre-hypertensive adults, and those at high risk of Cardiovascular disease.
A Fortune 500 multinational packaged foods company sought to drive growth in a legacy fiber snack bar brand by launching new product line extensions with a re-formulated fiber ingredient.